Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

In early April, President Donald Trump gathered dozens of hard-hat-clad coal miners around him in the White House East Room.

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Heavy smoking in adult males significantly increases oxidative stress, inflammation, and vascular dysfunction, as shown by ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

GLORY-3: A Phase 3 trial comparing mazdutide and semaglutide in Chinese participants with overweight/obesity and metabolic dysfunction-associated fatty liver disease (MAFLD). DREAMS-1: A Phase 3 trial ...